Interventions for fatigue in Parkinson’s disease
Abstract Background Factors contributing to subjective fatigue in people with idiopathic Parkinson’s disease (PD) are not well known. This makes it difficult to manage fatigue effectively in PD. Objectives To evaluate the effects of pharmacological and non-pharmacological interventions, compared to an inactive control intervention, on subjective fatigue in people with PD. Search methods We searched […]
Treadmill training for patients with Parkinson’s disease
Abstract Background Treadmill training is used in rehabilitation and is described as improving gait parameters of patients with Parkinson’s disease. Objectives To assess the effectiveness of treadmill training in improving the gait of patients with Parkinson’s disease and the acceptability and safety of this type of therapy. Search methods We searched the Cochrane Movement Disorders […]
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Abstract Background Tardive dyskinesia is a chronic and disabling abnormal movement disorder affecting the muscles of the face, neck, tongue and the limbs. It is a common side effect of long-term antipsychotic medication use in individuals with schizophrenia and other related psychotic disorders. While there are no known effective treatments for tardive dyskinesia to date, […]
Creatine for Parkinson’s disease
Abstract Background Parkinson’s disease is one of the most common neurodegenerative disorders and mitochondrial dysfunction plays an important role in its pathogenesis. Creatine is effective in improving mitochondrial function. It may therefore be useful for slowing the progression of Parkinson’s disease. Objectives To assess the efficacy and safety of creatine used alone or as an […]
Physiotherapy for Parkinson’s disease: a comparison of techniques
Abstract Background Despite medical therapies and surgical interventions for Parkinson’s disease (PD), patients develop progressive disability. The role of physiotherapy is to maximise functional ability and minimise secondary complications through movement rehabilitation within a context of education and support for the whole person. The overall aim is to optimise independence, safety and wellbeing, thereby enhancing […]
Physiotherapy versus placebo or no intervention in Parkinson’s disease
Abstract Background Despite medical therapies and surgical interventions for Parkinson’s disease (PD), patients develop progressive disability. Physiotherapy aims to maximise functional ability and minimise secondary complications through movement rehabilitation within a context of education and support for the whole person. The overall aim is to optimise independence, safety, and well-being, thereby enhancing quality of life. […]
Comparison of speech and language therapy techniques for speech problems in Parkinson’s disease
Abstract Background Patients with Parkinson’s disease commonly suffer from speech and voice difficulties such as impaired articulation and reduced loudness. Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids. Objectives To compare the efficacy and effectiveness of novel SLT techniques versus a standard SLT approach […]
Speech and language therapy versus placebo or no intervention for speech problems in Parkinson’s disease
Abstract Background Parkinson’s disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids. Objectives To compare […]
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease
Abstract Background Previous Cochrane reviews have considered the use of cholinesterase inhibitors in both Parkinson’s disease with dementia (PDD) and dementia with Lewy bodies (DLB). The clinical features of DLB and PDD have much in common and are distinguished primarily on the basis of whether or not parkinsonism precedes dementia by more than a year. […]
Whole-body vibration training for patients with neurodegenerative disease
Abstract Background Whole-body vibration (WBV) may be a complementary training to standard physical rehabilitation programmes and appears to have potential benefits in the sensorimotor system performance of patients with neurodegenerative diseases. Objectives The aim of this review was to examine the efficacy of WBV to improve functional performance according to basic activities of daily living […]